For authors

Submitting to BJC

BJC welcomes the submission of high quality original and innovative research findings that are relevant to understanding the etiology of cancer and to improving the treatment and survival of patients. See this page for information on what we accept, how to submit to BJC and what you can expect throughout the submission process.

Submitting to BJC

Author licence

From the beginning of Volume 97 (July 2007) BJC adopted a new Licence to Publish (LTP) This agreement has many benefits for authors. It allows authors to retain their copyright, whilst transferring to Cancer Research UK, the owners of BJC, the rights that they and NPG, the publisher of the journal, need in order to protect, publish, distribute and market papers to maximum effect.

Author Licence


Authors of accepted peer-reviewed original articles may choose to pay a fee in order for their published article to be made freely accessible immediately upon publication. See this page for more information on choosing this option for your paper.


Extra navigation